Pfizer CRZ 200 (Xalkori 200 mg)
Generic Name: crizotinib
Pill imprint Pfizer CRZ 200 has been identified as Xalkori 200 mg.
Xalkori is used in the treatment of non-small cell lung cancer and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Xalkori 200 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- crizotinib
- Imprint:
- Pfizer CRZ 200
- Strength:
- 200 mg
- Color:
- Pink & White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Multikinase inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Pfizer Inc.
More about Xalkori (crizotinib)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
